A Phase 1 Study Evaluating the Safety, Tolerability, and Immunogenicity of V4020 Vaccine in Healthy Volunteers

Clinical trial NCT07088822 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07088822
Sponsor: Medigen, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Venezuelan Equine Encephalitis Venezuelan Equine Encephalitis Virus Infection

Start date: 2025-08-15
Primary completion: 2026-02-28
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.